Financial Performance Overview
Laxmi Organic Industries Limited reported challenging FY26 results with standalone revenue declining 6% YoY to ₹28,085 million and net profit falling 32.7% to ₹793 million. The performance was impacted by feedstock deflation, acetic acid price volatility, and phase-out of key agrochemical intermediates representing ~10% of specialty segment revenue. The company recognized a ₹243.32 million GST incentive and reversed ₹407.27 million in liabilities following a favorable MERC order on electricity charges.
Operational and Strategic Developments
The company made significant progress on its expansion initiatives, commissioning Phase 1 of the Dahej facility while progressing Phase 2 mechanical completion. Strategic milestones included a partnership with Hitachi Energy for production of eco-efficient SF6-free switchgear gas and ramp-up of India's first commercial-scale Electrochemical Fluorination platform at Lote. The company changed its depreciation method from WDV to SLM, reducing FY26 depreciation expense by ₹1,126.49 million.
Financial Position and Capital Structure
Total assets included property, plant and equipment of ₹14,780 million and capital work-in-progress of ₹6,517 million, primarily for the Dahej expansion project (₹5,864 million). Net debt to equity ratio increased to 24.11% from 11.00% due to increased borrowings. The company maintained IND AA/Negative and CRISIL AA-/Negative credit ratings for term loans.
Governance and Compliance
The board recommended a final dividend of ₹0.30 per share (15% on face value). Auditors Deloitte Haskins & Sells LLP identified impairment assessment of ₹4.92 billion in fluorination process assets as a key audit matter but issued an unmodified opinion. The company paid managerial remuneration exceeding limits by ₹29.47 million, requiring shareholder approval. ESG initiatives showed progress with 11% renewable energy usage and zero hazardous effluent discharge.
Forward Outlook
Growth drivers include Dahej Phase 2 ramp-up, Hitachi Energy project qualification, and fluorination platform utilization improvement. The company faces challenges from feedstock volatility, global oversupply conditions, and geopolitical uncertainties. The 37th Annual General Meeting is scheduled for August 5, 2026.